Long-term side effects of curative treatment for breast cancer – data from the MaTox project. 6. Juni 2014 Hurtz, H.-J., Tesch, H., Göhler, T., Hutzschenreuter, U., Harde, J., Kruggel, L., Marschner, N., 2014. Oncol Res Treat 37 (suppl 5)(V370), 110. doi:10.1159/000368945 Abstract Multiple myeloma and neurotoxicity: Patient-reported and physician-recorded findings from the German prospective TLN Registry and the LyTox project. Hurtz, H.-J., Knauf, W., Hutzschenreuter, U., Mittermüller, J., Grugel, R., Harde, J., Boller, E., Hartmann, H., Marschner, N., 2014. Oncol Res Treat 37 (suppl 5)(P861),… Weiterlesen 1st-line treatment with BR and FCR in patients with chronic lymphocytic leukamia. Knauf, W., Abenhardt, W., Engel, E., Grugel, R., Harde, J., Jänicke, M., Marschner, N., 2014. Oncol Res Treat 37 (suppl5)(P186), 50. doi:10.1159/000368945… Weiterlesen